---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-022401"
form_type: "8-K"
ticker: "IMNN"
cik: "0000749647"
company_name: "Imunon, Inc."
filed_at: "2026-05-12T12:05:36+00:00"
generated_at: "2026-05-12T12:14:21.791242+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Imunon reports Q1 net loss $4.3M; Phase 2 ovarian data shows 14.7-month OS improvement

## Summary
- Net loss of $4.3M ($0.84 per share) vs $4.1M ($3.15 per share) in Q1 2025; cash $4.8M at March 31, 2026.
- Phase 2 OVATION 2 final data: median OS 45.1 vs 30.4 months (+14.7 months) for IMNN-001+SoC vs SoC alone.
- With PARP inhibitor maintenance, median OS 65.6 vs 41.4 months (+24.2 months) for IMNN-001 arm.
- Phase 3 OVATION 3 enrollment expected to complete by Q1 2029; FDA aligned on BLA path.
- Strategic reorganization in Feb 2026 reduced operating expenses; R&D expenses up to $2.3M from $2.2M.

## SEC filing metadata
- accession: 0001493152-26-022401
- form_type: 8-K
- ticker: IMNN
- cik: 0000749647
- company_name: Imunon, Inc.
- filed_at: 2026-05-12T12:05:36+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/749647/000149315226022401/0001493152-26-022401-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/749647/000149315226022401/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-022401
- JSON: https://secwatch.observer/filing/0001493152-26-022401.json
- Plain text: https://secwatch.observer/filing/0001493152-26-022401.txt

## Key facts
- Earnings Releases
  Imunon, Inc. reported the three months ended March 31, 2026 results: net income $4.3 million, EPS $0.84 per share.
  - Period: the three months ended March 31, 2026
  - Net income: $4.3 million
  - EPS: $0.84 per share
  - Result: reported results
  source text: Net loss for the first quarter of 2026 was $4.3 million, or $0.84 per share
  evidence_url: https://www.sec.gov/Archives/edgar/data/749647/000149315226022401/0001493152-26-022401-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.